1. Thakur KT, Albanese E, Giannakopoulos P, Jette N, Linde M, Prince MJ, Steiner TM, Dua T (2016) Chapter 5. Neurological disorders. In: Mental, neurological, and substance use disorders: disease control priorities, vol 4, 3rd edn. The International Bank for Reconstruction and Development/The World Bank, Washington, DC
2. Zis P, Hadjivassiliou M (2019) Treatment of neurological manifestations of gluten sensitivity and coeliac disease. Curr Treat Options Neurol 21(3):10
3. Sanders T, Liu Y, Buchner V, Tchounwou PB (2009) Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health 24(1):15–45
4. World Health Organization (2006) Neurological disorders: public health challenges. World Health Organization, Geneva
5. Lovrečić L, Maver A, Zadel M, Peterlin B (2013) The role of epigenetics in neurodegenerative diseases. In: Kishore U (ed) Neurodegenerative diseases. IntechOpen, London, pp 345–365